Showing results (181-190 of 291) with videos related to
Sort By:
Pageof 30
Bone Marrow Transplantation|May 4, 2018
Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantationMohamad Mohty, Rafael F Duarte, Jurgen Kuball, et al.Bone Marrow Transplantation|April 12, 2019
Transplant center practices for psychosocial assessment and management of pediatric hematopoietic stem cell donorsLori Wiener, Jennifer A Hoag, Wendy Pelletier, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2010
IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusionSabine Huenecke, Stefanie Yvonne Zimmermann, Stephan Kloess, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2026
First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in LeukemiaEva Rettinger, Dirk Heckl, Martin Hutter, et al.Bone Marrow Transplantation|March 5, 2020
Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC)Bruce Morland, Tomas Kepak, Sandro Dallorso, et al.Haematologica|October 5, 2019
Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow TransplantationAndré Tichelli, Régis Peffault de Latour, Jakob Passweg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?Peter Bader, Hermann Kreyenberg, Walter Hoelle, et al.Oncotarget|August 4, 2016
Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrowUwe Thiel, Angela Wawer, Irene von Luettichau, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2010
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromesNicolaus Kröger, Ulrike Bacher, Peter Bader, et al.Blood Advances|January 4, 2018
Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseasesJohn A Snowden, Manuela Badoglio, Myriam Labopin, et al.Pageof 30